Role of Osteonectin in Breast Cancer Bone Metastasis
骨连接素在乳腺癌骨转移中的作用
基本信息
- 批准号:6692587
- 负责人:
- 金额:$ 4.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-11-16 至 2004-11-15
- 项目状态:已结题
- 来源:
- 关键词:affinity chromatographyantisense nucleic acidathymic mousebinding proteinsbone neoplasmsbreast neoplasmscell linecell surface receptorsendopeptidasesenzyme activityimmunocytochemistryimmunoprecipitationmetastasisneoplasm /cancer invasivenessneoplastic growthosteonectinsurface plasmon resonancetransfection
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of this research
proposal is to elucidate mechanisms of breast cancer metastasis to bone.
Approximately, 60-70 percent of breast cancer patients who have died or are
dying of breast cancer have bone metastases. Osteonectin (OSN, SPARC, BM-40) is
a bone factor that has been found to be a chemo-attractant for breast and
prostrate cancer cells. In addition, increased OSN expression has been found in
breast cancer, however a connection between increased OSN expression in breast
cancer cells and bone metastasis has not been proven. Surprisingly, a cell
surface receptor has yet to be identified. This proposal will test the central
hypothesis that increased expression of OSN in breast cancer cells increases
tumor growth and metastasis to bone, and binding of OSN to its cell surface
receptor is important for this process. Specific aim 1 will determine if
altered expression of OSN in breast cancer cells will affect tumor cell growth,
invasion and protease activity in vitro and specific aim 2 will examine if this
altered expression of OSN affects tumor cell growth in the mammary fat pad, in
bone and in metastasis to bone in vivo. Specific aim 3 will establish if OSN
binds to the cell surface and characterize the cell surface binding protein. A
variety of approaches will be utilized to elucidate the role OSN in breast
cancer bone metastasis and to identify OSN surface binding proteins.
Identification of the OSN binding protein and determining the role of
endogenous production of OSN by breast cancer cells may lead to better
diagnostic and/or therapeutic approaches for breast cancer.
描述(由申请人提供):本研究的长期目标
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JENNIFER E KOBLINSKI其他文献
JENNIFER E KOBLINSKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JENNIFER E KOBLINSKI', 18)}}的其他基金
A laminin peptide increases breast cancer bone metastasis
层粘连蛋白肽可增加乳腺癌骨转移
- 批准号:
7501968 - 财政年份:2007
- 资助金额:
$ 4.78万 - 项目类别:
A laminin peptide increases breast cancer bone metastasis
层粘连蛋白肽可增加乳腺癌骨转移
- 批准号:
7384642 - 财政年份:2007
- 资助金额:
$ 4.78万 - 项目类别:
A laminin peptide increases breast cancer bone metastasis
层粘连蛋白肽可增加乳腺癌骨转移
- 批准号:
7680275 - 财政年份:2007
- 资助金额:
$ 4.78万 - 项目类别:
Role of Osteonectin in Breast Cancer Bone Metastasis
骨连接素在乳腺癌骨转移中的作用
- 批准号:
6445694 - 财政年份:2001
- 资助金额:
$ 4.78万 - 项目类别:
Role of Osteonectin in Breast Cancer Bone Metastasis
骨连接素在乳腺癌骨转移中的作用
- 批准号:
6685697 - 财政年份:2001
- 资助金额:
$ 4.78万 - 项目类别:
相似海外基金
Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
- 批准号:
22K09003 - 财政年份:2022
- 资助金额:
$ 4.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
- 批准号:
21K07762 - 财政年份:2021
- 资助金额:
$ 4.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
- 批准号:
20K16927 - 财政年份:2020
- 资助金额:
$ 4.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
- 批准号:
20H00526 - 财政年份:2020
- 资助金额:
$ 4.78万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
- 批准号:
20K21245 - 财政年份:2020
- 资助金额:
$ 4.78万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
- 批准号:
G0900887/1 - 财政年份:2011
- 资助金额:
$ 4.78万 - 项目类别:
Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
- 批准号:
05558090 - 财政年份:1993
- 资助金额:
$ 4.78万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
- 批准号:
04453031 - 财政年份:1992
- 资助金额:
$ 4.78万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)














{{item.name}}会员




